Treatment(s) now being considered-Percutaneous coronary intervention (PCI) Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Percutaneous coronary intervention (PCI) Posts on Medivizor

P2Y12 inhibitors – is monotherapy a safe management strategy after percutaneous coronary intervention?

Posted by on Jul 21, 2019 in Coronary artery disease | 0 comments

In a nutshell This study investigated the effect of dual antiplatelet therapy (APT) compared to P2Y12 inhibitors on outcomes after a percutaneous coronary intervention (PCI).   They found that the rate of cardiac events was similar in patients treated with P2Y12 inhibitors or dual APT.  Some background Coronary artery disease (CAD)...

Read More

The effects of widening blood vessels on maximum blood flow to the heart in patients with coronary artery disease

Posted by on Feb 28, 2019 in Coronary artery disease | 0 comments

In a nutshell This study aimed to investigate the effects of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) on maximum blood flow in patients with coronary artery disease (CAD). The main finding of the study was that these procedures stopped the decrease in maximum blood flow through the heart arteries. Some...

Read More

Can a big first dose of atorvastatin lower poor outcomes in patients with heart attacks?

Posted by on Jan 27, 2019 in Coronary artery disease | 0 comments

In a nutshell The aim of this study was to investigate if a large first dose (loading dose) of atorvastatin (Lipitor) can reduce major adverse cardiovascular events (MACE) in patients with heart attacks and unstable angina. Some background Acute coronary syndrome (ACS) is a term which describes heart attacks and unstable angina A heart attack is a...

Read More

Stents vs. bypass – a 10 year follow-up in patients with coronary heart disease

Posted by on Nov 3, 2018 in Coronary artery disease | 0 comments

In a nutshell This study investigated the long-term outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) to treat coronary heart disease (CHD). They found that CABG was associated with a longer-term benefit than PCI. Some background Coronary heart disease (CHD) is caused by blockages to the vessels...

Read More

Is angioplasty as safe as coronary artery bypass grafting in people with left main coronary artery disease?

Posted by on Nov 9, 2017 in Coronary artery disease | 0 comments

In a nutshell This study compared the safety of percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) to coronary artery bypass grafting (CABG) in patients with left main coronary artery disease (LMCAD). It determined that PCI and CABG were equally safe, mortality-wise. However, PCI was associated with more non-fatal heart attacks,...

Read More

Comparing treatment methods for non-ST elevation acute coronary syndrome

Posted by on Nov 9, 2017 in Coronary artery disease | 0 comments

In a nutshell This study aimed to compare the outcomes of coronary artery bypass grafting and percutaneous coronary intervention with drug eluting stents in patients with non-ST elevation acute coronary syndrome. This study concluded that non-ST elevation acute coronary syndrome patients treated with coronary artery bypass grafting had better...

Read More

Can percutaneous coronary intervention lead to depression and anxiety?

Posted by on Sep 10, 2017 in Coronary artery disease | 0 comments

In a nutshell This study aimed to investigate the prevalence of depression and anxiety symptoms in patients with myocardial infarction who are treated with primary percutaneous coronary intervention. This study concluded that these patients had low rates of depression and anxiety symptoms following treatment, but these symptoms may increase after a...

Read More

How long should dual antiplatelet therapy be given after a drug-eluting stent insertion?

Posted by on Sep 19, 2016 in Coronary artery disease | 0 comments

In a nutshell This paper studied how long dual antiplatelet therapy should be given for after a drug-eluting stent insertion. The authors concluded that continuing dual antiplatelet therapy beyond 12 months can be carefully considered in selected patients with low bleeding risk.  Some background A drug-eluting stent is a mesh wire structure...

Read More